Wang, Tong
Postdoctoral Associate
Dr. Wang joined the Greenwood Genetic Center in December 2018 as a Postdoctoral Associate in Dr. Rich Steet's group. Her previous postdoc training in the
Neuroscience Department at the Medical College of Georgia involved work on the roles of dscaml1 in somatosensory development, focusing on retinal circuits
in larvae zebrafish. At GGC, her research addresses questions regarding lysosomal disease pathogenesis - how glycosaminoglycans impact cathepsin protease
function during chondrogenesis utilizing newly-developed mutant and transgenic zebrafish lines. A long-standing interest of the group is to explore
novel therapeutic modalities, such as cathepsin inhibition, for the treatment of lysosomal diseases and develop novel zebrafish tools to facilitate
high throughput drug screens for a variety of rare genetic disorders.
Contact Information
Office (864) 388-1802
twang@ggc.org
Education
- B.S. (Clinical Medicine), Shenyang Medical College, China, 1999
- M.S. (Cell Biology), China Medical University, China, 2004
- Ph.D. (Oncology), China Medical University, China, 2013
Professional Appointments
- Research Associate, Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta University, 2014-2017
- Postdoctoral Fellow, Department of Periodontics, Dental College of Georgia, Augusta University, 2017-2018
- Postdoctoral Associate, Greenwood Genetic Center, 2018-present
Selected Publications
- Wang, T., Cui H.X., Ma N., Jiang Y.H.. Nicotinamide mediated inhibition of SIRT1 deacetylase is associated with the viability of cancer
cells exposed to antitumor agents and apoptosis. Oncology letters, 2013 Aug;6(2):600-604
- Tong Wang, Danni Li, Yong Li, Jie Wang. Inhibition of VEGF receptor KDR gene expression in A549 cell line by Lentivirus-mediated siRNA.
Clinical Engineering, 2012, 19(10): 1664-1666
- Tong Wang, Danni Li, Yong Li, Jie Wang. Optimization of oligonucleotide probe fabrication. Letters in Biotechnology, 2010,21(4):564-567
- Tong Wang, Jie Wang. Association of Fms-like tyrosine kinase-3 mutation with the occurrence and prognosis of leukemia in patients
with leukemia. Journal of Clinical Rehabilitative Tissue Engineering Research, 2007, 11(37): 7509-7512
- Tong Wang, Tianjiao Wang, He Qun, Zhang Yukui, Ma Jiaming, Hou Weijian, Wang Shaocheng, Pan Zhongcheng, Zhao Yujie. HLA-DQA1 genotyping
by oligonucleotide microarrays. Journal of Experimental Hematology, 2006,14(1): 142-145
